Evercore ISI Group analyst Kirk Materne maintains Intuit (NASDAQ:INTU) with a Outperform and raises the price target from $500 to $601.
PDS Biotechnology To Rally Around 129%? Here Are 5 Other Price Target Changes For Tuesday
Chardan Capital raised PDS Biotechnology Corporation (NASDAQ:PDSB) price target from $15 to $16. . Chardan Capital analyst Geulah…